These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8271378)

  • 1. [A synthetic peptide "T22" as anti-HIV agents].
    Nakashima H; Murakami T
    Nihon Rinsho; 1993 Sep; 51 Suppl():146-52. PubMed ID: 8271378
    [No Abstract]   [Full Text] [Related]  

  • 2. The synthetic [Tyr5,12,Lys7]-polyphemusin II peptide (T22) binds to the CD4 cell surface molecule.
    Weeks BS; Nomizu M; Otaka A; Weston CA; Okusu A; Tamamura H; Yamamoto N; Fujii N
    Biochem Biophys Res Commun; 1995 Oct; 215(2):626-31. PubMed ID: 7488001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of an anti-HIV peptide, T22, with gp120 and CD4.
    Tamamura H; Otaka A; Murakami T; Ishihara T; Ibuka T; Waki M; Matsumoto A; Yamamoto N; Fujii N
    Biochem Biophys Res Commun; 1996 Feb; 219(2):555-9. PubMed ID: 8605026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of an anti-HIV peptide, T22.
    Tamamura H; Murakami T; Masuda M; Otaka A; Takada W; Ibuka T; Nakashima H; Waki M; Matsumoto A; Yamamoto N
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1729-35. PubMed ID: 7811258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion.
    Nakashima H; Masuda M; Murakami T; Koyanagi Y; Matsumoto A; Fujii N; Yamamoto N
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1249-55. PubMed ID: 1384424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.
    Jenssen H; Andersen JH; Mantzilas D; Gutteberg TJ
    Antiviral Res; 2004 Nov; 64(2):119-26. PubMed ID: 15498607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II).
    Masuda M; Nakashima H; Ueda T; Naba H; Ikoma R; Otaka A; Terakawa Y; Tamamura H; Ibuka T; Murakami T
    Biochem Biophys Res Commun; 1992 Dec; 189(2):845-50. PubMed ID: 1472056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of amino acid replacements, additions and deletions on the antiviral activity of a peptide derived from the HIV-1 GP41 sequence.
    Jiang S; Lin K
    Pept Res; 1995; 8(6):345-8. PubMed ID: 8838418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An anti-HIV peptide, T22, forms a highly active complex with Zn(II).
    Tamamura H; Otaka A; Murakami T; Ibuka T; Sakano K; Waki M; Matsumoto A; Yamamoto N; Fujii N
    Biochem Biophys Res Commun; 1996 Dec; 229(2):648-52. PubMed ID: 8954952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiviral compounds: current approaches for development].
    Suzutani T; Azuma M
    Nihon Rinsho; 1993 Jul; 51(7):1907-14. PubMed ID: 8366615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of activity, synthesis and biological testing of anti-HSV active peptides.
    Jenssen H; Gutteberg TJ; Rekdal Ø; Lejon T
    Chem Biol Drug Des; 2006 Jul; 68(1):58-66. PubMed ID: 16923027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular parameters for the anti-human immunodeficiency virus activity of T22 ([Tyr5,12, Lys7]-polyphemusin II).
    Otaka A; Tamamura H; Terakawa Y; Masuda M; Koide T; Murakami T; Nakashima H; Matsuzaki K; Miyajima K; Ibuka T
    Biol Pharm Bull; 1994 Dec; 17(12):1669-72. PubMed ID: 7735216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.
    Wild C; Oas T; McDanal C; Bolognesi D; Matthews T
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10537-41. PubMed ID: 1438243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity.
    Tamamura H; Murakami T; Horiuchi S; Sugihara K; Otaka A; Takada W; Ibuka T; Waki M; Yamamoto N; Fujii N
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):853-8. PubMed ID: 7553971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of HIV inhibition by modified antisense oligonucleotides.
    Abramova T; Blinov V; Vlassov V; Gorn V; Zarytova V; Ivanova E; Konevets D; Plyasunova O; Pokrovsky A; Sandakhchiev L
    Nucleic Acids Symp Ser; 1991; (24):283. PubMed ID: 1841341
    [No Abstract]   [Full Text] [Related]  

  • 16. NMR structure of mussel mytilin, and antiviral-antibacterial activities of derived synthetic peptides.
    Roch P; Yang Y; Toubiana M; Aumelas A
    Dev Comp Immunol; 2008; 32(3):227-38. PubMed ID: 17628674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HIV activity and conformational studies of peptides derived from the C-terminal sequence of SDF-1.
    Dettin M; Pasquato A; Scarinci C; Zanchetta M; De Rossi A; Di Bello C
    J Med Chem; 2004 Jun; 47(12):3058-64. PubMed ID: 15163187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the solution structures of tachyplesin I and a novel anti-HIV synthetic peptide, T22 ([Tyr5,12, Lys7]-polyphemusin II), determined by nuclear magnetic resonance.
    Tamamura H; Kuroda M; Masuda M; Otaka A; Funakoshi S; Nakashima H; Yamamoto N; Waki M; Matsumoto A; Lancelin JM
    Biochim Biophys Acta; 1993 May; 1163(2):209-16. PubMed ID: 8490053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4(81-92)-based peptide derivatives. Structural requirements for blockade of HIV infection, blockade of HIV-induced syncytium formation, and virostatic activity in vitro.
    Rausch DM; Lifson JD; Padgett MP; Chandrasekhar B; Lendvay J; Hwang KM; Eiden LE
    Biochem Pharmacol; 1992 Apr; 43(8):1785-96. PubMed ID: 1575773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3'-Fluoro-deoxythymidine-5-fluorophosphate--an effective inhibitor of reproduction of human immunodeficiency virus in cell cultures].
    Arzumanov AA; Diatkina NB; Kukhanova MK; Kraevskiĭ AA; Semchenko FM; Eremin OG; Martynov BI
    Bioorg Khim; 1993 Oct; 19(10):978-80. PubMed ID: 8274172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.